AstraZeneca stock heads into the open after a 1.2% London gain

At the close on September 17, 2026, AstraZeneca stock in London was up 1.2 percent, with the shares trading around 122.85 GBP and outperforming a broadly higher global equity backdrop after solid quarterly figures reported earlier in the week.

AstraZeneca stock closed the last session on the London Stock Exchange at 122.85 GBP on September 17, 2026, up 1.2% from the previous close. Compared with a global rally that lifted major United States indices by around 1.1% to 1.7% on the same day, the move left the shares still well below their recent 52-week high but comfortably above the 52-week low.

September 17, 2026 in numbers

AstraZeneca Plc (ISIN US6549022043) traded around 122.85 GBP during the September 17, 2026 London session, with intraday reports showing the shares higher by between 0.7% and 1.2% as midday trading progressed. As Finanzen.ch reported from the London market, the stock was up 1.2% at 122.85 GBP in the morning session on September 17, 2026. A separate midday update from Finanzen.ch noted the shares 0.7% higher at 122.26 GBP, confirming modest gains through the session.

According to a market wrap citing the same London pricing, the current level left AstraZeneca stock roughly 21.9% below a 52-week high of about 157.30 GBP while standing above a 52-week low near 107.84 GBP, underscoring that the latest advance came within a still wide range for the year. The broader backdrop was supportive: United States equities rallied on September 17, 2026, with the S&P 500 index up about 1.1% to around 7,637 points and the Nasdaq Composite gaining roughly 1.7%, as reported in coverage of the Wall Street close by AP News.

Today's lens on AstraZeneca

Into today's session on September 18, 2026, investors are watching AstraZeneca after recent commentary highlighted solid earnings momentum. A consensus review from MarketBeat on September 17, 2026, noted that AstraZeneca recently reported quarterly core earnings per share of 2.63 in its reporting currency, ahead of a 2.50 consensus, alongside revenue growth of about 6.4% year on year, reinforcing a positive fundamental backdrop heading into the open.